Incidental findings from cancer next generation sequencing panels
Abstract Next-generation sequencing (NGS) technologies have facilitated multi-gene panel (MGP) testing to detect germline DNA variants in hereditary cancer patients. This sensitive technique can uncover unexpected, non-germline incidental findings indicative of mosaicism, clonal hematopoiesis (CH),...
Guardado en:
Autores principales: | Nika Maani, Karen Panabaker, Jeanna M. McCuaig, Kathleen Buckley, Kara Semotiuk, Kirsten M. Farncombe, Peter Ainsworth, Seema Panchal, Bekim Sadikovic, Susan Randall Armel, Hanxin Lin, Raymond H. Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/51d40d0aa8aa4187b039858a26fe2992 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours.
por: John Bartlett, et al.
Publicado: (2021) -
Promoting Stress Management and Wellbeing for Teachers, A Pilot Study
por: Stevie-Jae Hepburn, et al.
Publicado: (2021) -
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
por: Arnaud Bayle, et al.
Publicado: (2021) -
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
por: Blanca de Unamuno Bustos, et al.
Publicado: (2017) -
Los incidentes
por: Salas, Julio